Kidney Stone Management Market Analysis

Kidney Stone Management Market Analysis

Based on type, the market is categorized into calcium oxalate, calcium phosphate, uric acid, struvite, and cysteine. The calcium oxalate segment held majority market share with a revenue of USD 1.9 billion in 2023.
 

• Calcium oxalate stones are the most common type of kidney stones, accounting for about 75-80% of all cases. Their prevalence is significantly higher compared to other types of stones, making them the dominant segment.
   
• Moreover, diets rich in oxalate-containing foods (such as spinach, nuts, and chocolate) and high in calcium can increase the risk of calcium oxalate stone formation. Such factors are anticipated to contribute to the segmental growth.
   

Based on diagnostics, the kidney stone management market is categorized into abdominal x-rays, computed tomography, ultrasound, abdominal MRI, intravenous pyelography, and other diagnostics. The computed tomography segment accounted for leading share in 2023 and anticipated to reach USD 1.3 billion by 2032.
 

• CT scans can be performed quickly, often within minutes, making them ideal for emergency settings where rapid diagnosis is critical.
   
• Additionally, CT is a non-invasive diagnostic tool that does not require any special preparation or contrast agents, making it suitable for a wide range of patients. Hence these factors contribute to its increased preference among healthcare professionals.
   

Based on treatment, the kidney stone management market is categorized into extracorporeal shock wave lithotripsy (ESWL), ureteroscopy, percutaneous nephrolithotomy (PCNL), and other treatments. The extracorporeal shock wave lithotripsy segment dominated the market with a market share of 58.2% in 2023.
 

• ESWL is a non-invasive treatment option that uses shock waves to break kidney stones into smaller fragments that can be passed naturally through the urinary tract.
   
• Moreover, the success rate of ESWL is high, especially for stones that are composed of materials that fragment easily, such as calcium oxalate and uric acid stones. Thus, owing to such features extracorporeal shock wave lithotripsy treatment type is anticipated to contribute substantially to the market growth.
   

Based on end-use, the kidney stone management market is categorized into hospitals, specialty clinics, ambulatory surgical centers, and other end-users. The hospitals segment dominated the market with a revenue of USD 1.3 billion in 2023.

• Hospitals are equipped to manage emergencies, such as acute renal colic or severe complications from kidney stones, which often require immediate medical intervention. The presence of emergency departments ensures that patients can receive prompt and comprehensive care at any time.
   
• Moreover, hospitals typically have access to the latest medical technologies and equipment required for effective kidney stone management, including advanced medical imaging systems, laser lithotripters, and surgical robots systems. Hence the availability of aforementioned treatment modalities in the hospital settings is anticipated to contribute to the segmental growth.
   

North America kidney stone management market accounted for USD 1.1 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• The prevalence of kidney stones in North America has been increasing due to dietary and lifestyle factors. Diets high in salt, protein, and oxalate-rich foods, combined with low fluid intake, contribute to higher rates of kidney stone formation cases in the region.
   
• Additionally, North America boasts advanced healthcare infrastructure, including well-equipped hospitals and specialty clinics that provide comprehensive kidney stone management services to the patients.
   

The U.S. kidney stone management market is anticipated to reach USD 1.5 billion by 2032.
 

• Favourable insurance policies in the U.S. ensure that a significant portion of the costs associated with kidney stone diagnosis and treatment is covered. This includes coverage for advanced treatments and surgical procedures.
   
• Furthermore, reimbursement policies that support kidney function tests or advanced diagnostic tests and minimally invasive treatments encourage patients to seek early and appropriate care.
   

The kidney stone management market in the UK is expected to experience significant and promising growth from 2024 to 2032.
 

• The UK has a well-developed healthcare infrastructure with advanced diagnostic and treatment facilities for kidney stone management. This includes hospitals equipped with the latest technology and specialized urology clinics.
   
• Additionally, there are ongoing public health campaigns in the UK to raise awareness about kidney stones, their symptoms, and preventive measures. Increased awareness leads to early diagnosis and timely treatment, improving patient outcomes, and increasing demand for kidney stone management.
   

Japan kidney stone management market is anticipated to witness lucrative growth between 2024 – 2032.
 

• Government initiatives aimed at improving public health and reducing the burden of kidney stones, such as funding for research, public awareness campaigns, and policies promoting healthy lifestyles support market growth.
   
• Furthermore, Japan is actively involved in clinical research and trials focused on kidney stone management. Ongoing research efforts aim to understand the pathophysiology of kidney stones, develop new treatments, and improve existing technologies.